New Technologies for Improving and Controlling Product Quality, Yields and Timelines in Upstream Process Development

Introduction The biologics industry has significantly advanced since the first generation of biologics emerged in the 1980s. Biologics have been demonstrated to be efficacious and safe in treating an increasing repertoire of diseases from cancer to autoimmune indications, and this has fuelled contin...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy